Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lytic Cycle of Bacteriophages01:30

Lytic Cycle of Bacteriophages

60.2K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
60.2K
DNA Bacteriophages01:26

DNA Bacteriophages

1.6K
Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
1.6K
Viral Replication: Lytic Cycle01:20

Viral Replication: Lytic Cycle

3.0K
Bacteriophages, or phages, are viruses that specifically infect bacteria. Among them, T-even bacteriophages, such as T4, exhibit a well-characterized lytic replication cycle in Escherichia coli (E. coli). This process ensures the rapid proliferation of the virus while ultimately leading to the destruction of the bacterial host.Attachment and DNA InjectionThe infection process begins with the recognition and binding of the T4 phage to the E. coli cell surface. Tail fibers of the phage...
3.0K
Viral Replication: Lysogenic Cycle01:16

Viral Replication: Lysogenic Cycle

2.7K
The lysogenic cycle is a crucial viral replication strategy that allows bacteriophages to persist within host cells without immediately destroying them. This process is primarily observed in temperate phages, such as bacteriophage lambda (λ), which infects Escherichia coli. The cycle allows the viral genome to persist across bacterial generations while keeping host cells viable.Integration of the Viral GenomeUpon infection, bacteriophage lambda attaches to the bacterial surface and injects...
2.7K
Lysogenic Cycle of Bacteriophages00:43

Lysogenic Cycle of Bacteriophages

49.8K
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
49.8K
Regulation of Bacterial Virulence01:28

Regulation of Bacterial Virulence

76
Pathogenic bacteria employ a range of regulatory mechanisms to modulate the expression of virulence genes in response to environmental and host-derived signals. These mechanisms ensure that virulence factors are expressed only under favorable conditions, thereby optimizing infection and survival strategies.Mechanisms of Virulence RegulationKey regulatory strategies include:Two-Component Systems: These consist of a membrane-bound sensor kinase and a cytoplasmic response regulator. Environmental...
76

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic Toolbox Expansion Enables Constitutively Fluorescent Lacticaseibacillus rhamnosus for Functional Microbiome Research.

Microbial biotechnology·2026
Same author

Organic light-emitting diode-based photodynamic therapy treats bacterial infection in a preclinical <i>ex vivo</i> burn wound model.

Burns & trauma·2026
Same author

DepoCatalog: mapping diversity of 129 recombinantly produced Klebsiella phage depolymerases.

Nature communications·2026
Same author

Modular biosynthesis of microbiome-derived polyketides and nonribosomal peptides: insights and opportunities for Lactobacillaceae.

Microbial cell factories·2026
Same author

Pyrogenicity of phage active pharmaceutical ingredients used for personalized therapy in Belgium.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V·2026
Same author

Exopolysaccharides of Lactobacillus crispatus mediate key balancing interactions with the vaginal mucosa.

NPJ biofilms and microbiomes·2026

Related Experiment Video

Updated: May 5, 2026

Using Phage Display to Develop Ubiquitin Variant Modulators for E3 Ligases
06:30

Using Phage Display to Develop Ubiquitin Variant Modulators for E3 Ligases

Published on: August 27, 2021

2.6K

Hurdles in bacteriophage therapy: deconstructing the parameters.

Jessica Tsonos1, Dieter Vandenheuvel2, Yves Briers2

  • 1Viral Genetics Research Group, Vrije Universiteit Brussel, Pleinlaan 2, 1050 Brussels, Belgium; Structural and Molecular Microbiology, VIB, Vrije Universiteit Brussel, Pleinlaan 2, 1050 Brussels, Belgium; Department Structural Biology, VIB, Vrije Universiteit Brussel, Pleinlaan 2, 1050 Brussels, Belgium; Laboratory of Gene Technology, KU Leuven, Kasteelpark Arenberg 21, 3001 Leuven, Belgium.

Veterinary Microbiology
|December 10, 2013
PubMed
Summary

Bacteriophage therapy shows promise for treating bacterial infections in animals and food production. However, inconsistent outcomes highlight the need for more research into phage behavior within the body.

Keywords:
Phage kineticsPhage therapyPhage translocationState of bacteria in vivo

More Related Videos

Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library
10:17

Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library

Published on: January 14, 2020

7.3K
Author Spotlight: Efficiently Eliminating Bacteriophages from Infected Salmonella Cultures Using Lipopolysaccharides
07:19

Author Spotlight: Efficiently Eliminating Bacteriophages from Infected Salmonella Cultures Using Lipopolysaccharides

Published on: June 28, 2024

1.6K

Related Experiment Videos

Last Updated: May 5, 2026

Using Phage Display to Develop Ubiquitin Variant Modulators for E3 Ligases
06:30

Using Phage Display to Develop Ubiquitin Variant Modulators for E3 Ligases

Published on: August 27, 2021

2.6K
Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library
10:17

Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library

Published on: January 14, 2020

7.3K
Author Spotlight: Efficiently Eliminating Bacteriophages from Infected Salmonella Cultures Using Lipopolysaccharides
07:19

Author Spotlight: Efficiently Eliminating Bacteriophages from Infected Salmonella Cultures Using Lipopolysaccharides

Published on: June 28, 2024

1.6K

Area of Science:

  • Veterinary Medicine
  • Microbiology
  • Biotechnology

Background:

  • Bacterial infections in animals pose significant economic threats to food production.
  • The rise of antibiotic-resistant pathogens necessitates novel therapeutic strategies.
  • Bacteriophage therapy, utilizing bacterial viruses, is re-emerging as a potential solution.

Purpose of the Study:

  • To critically evaluate the current state of bacteriophage therapy for animal infections.
  • To identify understudied parameters limiting the efficacy and consistency of phage therapy.
  • To emphasize the need for further research to overcome therapeutic variability.

Main Methods:

  • Review of existing literature on bacteriophage therapy in animal models.
  • Analysis of factors influencing phage efficacy in vivo.
  • Critical assessment of challenges in phage pharmacokinetics and host-receptor interactions.

Main Results:

  • While bacteriophage therapy demonstrates potential, its success is highly variable.
  • Key challenges include poorly understood phage distribution, variable receptor expression, and non-linear pharmacokinetics.
  • These factors complicate in vivo application and contribute to trial variability.

Conclusions:

  • Bacteriophage therapy holds significant promise but requires deeper investigation.
  • Addressing understudied parameters is crucial for optimizing phage therapy outcomes.
  • Further research is essential to unlock the full potential of bacteriophages as antimicrobials in animal health.